August 9, 2026
A New Frontier in Cancer Treatment: IgE Antibodies Harness the Immune System Against Resistant Tumours a-new-frontier-in-cancer-treatment-ige-antibodies-harness-the-immune-system-against-resistant-tumours

A New Frontier in Cancer Treatment: IgE Antibodies Harness the Immune System Against Resistant Tumours

Nana Wu July 16, 2026
London, UK – In a significant stride towards more targeted and less toxic cancer therapies, scientists at...
Read More Read more about A New Frontier in Cancer Treatment: IgE Antibodies Harness the Immune System Against Resistant Tumours
BIOTRONIK Neuro Accelerates Chronic Pain Innovation with Strategic Acquisition of Soin Neuroscience IP biotronik-neuro-accelerates-chronic-pain-innovation-with-strategic-acquisition-of-soin-neuroscience-ip

BIOTRONIK Neuro Accelerates Chronic Pain Innovation with Strategic Acquisition of Soin Neuroscience IP

Dwi Wanna July 16, 2026
In a significant move to reshape the landscape of neuromodulation therapy, BIOTRONIK Neuro has announced the acquisition...
Read More Read more about BIOTRONIK Neuro Accelerates Chronic Pain Innovation with Strategic Acquisition of Soin Neuroscience IP
Beyond the "All Clear": Breast Cancer Canada Launches Landmark Strategy to Redefine Survivorship beyond-the-all-clear-breast-cancer-canada-launches-landmark-strategy-to-redefine-survivorship

Beyond the "All Clear": Breast Cancer Canada Launches Landmark Strategy to Redefine Survivorship

Raul Delapena Setiawan July 16, 2026
As medical advancements continue to push survival rates for breast cancer to unprecedented levels, a new, complex...
Read More Read more about Beyond the "All Clear": Breast Cancer Canada Launches Landmark Strategy to Redefine Survivorship
Milestone Reached in MN-166 ALS Study: SEANOBI-ALS Trial Completes Patient Enrollment, Ushering in New Era of Hope milestone-reached-in-mn-166-als-study-seanobi-als-trial-completes-patient-enrollment-ushering-in-new-era-of-hope

Milestone Reached in MN-166 ALS Study: SEANOBI-ALS Trial Completes Patient Enrollment, Ushering in New Era of Hope

Siti Muinah July 16, 2026
San Diego, CA – [Date of Publication] – In a significant development for the amyotrophic lateral sclerosis...
Read More Read more about Milestone Reached in MN-166 ALS Study: SEANOBI-ALS Trial Completes Patient Enrollment, Ushering in New Era of Hope

You may have missed

advocacy-in-the-face-of-vulnerability-metavivor-urges-fda-to-expand-covid-19-vaccine-access-for-the-metastatic-breast-cancer-community

Advocacy in the Face of Vulnerability: METAvivor Urges FDA to Expand COVID-19 Vaccine Access for the Metastatic Breast Cancer Community

Laily UPN August 9, 2026
mastering-the-revolved-triangle-a-timeless-study-in-balance-and-alignment

Mastering the Revolved Triangle: A Timeless Study in Balance and Alignment

Asep Darmawan August 9, 2026
bridging-the-gap-how-one-program-is-reshaping-the-biotechnology-workforce

Bridging the Gap: How One Program is Reshaping the Biotechnology Workforce

Nana Muazin August 9, 2026
breakthrough-in-brain-tumour-diagnosis-promises-rapid-life-saving-interventions

Breakthrough in Brain Tumour Diagnosis Promises Rapid, Life-Saving Interventions

Asro August 9, 2026